Notice: Our Customer Service 1-800 line is currently down. To contact Customer Service within the United States, please call 1-203-702-7660. We apologize for any inconvenience.
This latest iteration in the AIChE PD2M workshop series addresses the question of what pharmaceutical manufacturing will look like in 2030 and how we should prepare now to be ready for the changes that are coming. It follows on from previous workshops on Continuous Manufacturing (Bethesda, 2016 and Ireland 2017)...
and the Future of Manufacturing (Washington 2019).
We have assembled a group of excellent chairs and speakers leading or working at the cutting edge of manufacturing technology development. These include senior regulatory, industry, and academic leaders. The event will be online, with sessions spread over three half-days. There will be ample opportunities for live discussion.
Presentations will address:
- Why the industry needs to embrace new ways to develop and manufacture medicines; including small molecules, biopharmaceuticals, vaccines and ATMPs
- How manufacturing needs to adapt to new modalities for medical treatment including ATMPs, making them both affordable and safe
- The impact of the wave of disruptive technologies referred to as Industry 4.0, including Industrial Internet of Things (IIoT), machine learning (ML), automation, robotics, advanced analytics and 3-d printing
- The role of enabling technologies for example continuous manufacturing in alleviating drug shortages and shortening supply chains
- Making future manufacturing systems flexible and modular
- The value of collaboration and standardization around these topics in order to avoid diluted effort as pharmaceutical companies, CMOs, CROs and their vendors move forward.
This workshop will be of interest to:
- Leaders, scientists and engineers working in pharmaceutical development and manufacturing functions, including technical operations and manufacturing science and technology
- Innovators, generics, CMOs and CROs
- Members of Regulatory and Quality functions and those involved in preparing regulatory submissions
- Pharmaceutical development and manufacturing innovators, including technology and software vendors
- Consultants and systems integrators providing assistance with delivery of technology projects and implementation